Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| GABAergic neuron | 3 studies | 36% ± 9% | |
| glutamatergic neuron | 3 studies | 44% ± 13% | |
| oligodendrocyte precursor cell | 3 studies | 23% ± 5% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 30% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 100% | 455.49 | 245 / 245 | 100% | 9.28 | 501 / 502 |
| brain | 99% | 379.25 | 2611 / 2642 | 100% | 13.86 | 705 / 705 |
| thymus | 100% | 383.88 | 653 / 653 | 98% | 7.76 | 595 / 605 |
| adrenal gland | 100% | 504.08 | 258 / 258 | 98% | 10.15 | 226 / 230 |
| breast | 100% | 390.56 | 459 / 459 | 97% | 8.49 | 1090 / 1118 |
| uterus | 100% | 539.38 | 170 / 170 | 97% | 8.84 | 447 / 459 |
| lung | 100% | 373.12 | 577 / 578 | 97% | 8.56 | 1124 / 1155 |
| bladder | 100% | 423.67 | 21 / 21 | 96% | 8.21 | 485 / 504 |
| esophagus | 100% | 312.07 | 1438 / 1445 | 96% | 7.31 | 175 / 183 |
| kidney | 100% | 288.38 | 89 / 89 | 94% | 7.11 | 849 / 901 |
| liver | 100% | 263.54 | 226 / 226 | 93% | 5.59 | 378 / 406 |
| pancreas | 96% | 179.16 | 315 / 328 | 93% | 5.46 | 166 / 178 |
| ovary | 100% | 717.86 | 180 / 180 | 89% | 5.28 | 383 / 430 |
| skin | 97% | 369.49 | 1756 / 1809 | 91% | 10.14 | 430 / 472 |
| intestine | 100% | 384.66 | 965 / 966 | 86% | 4.87 | 454 / 527 |
| stomach | 98% | 228.84 | 353 / 359 | 87% | 5.12 | 249 / 286 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 8.37 | 29 / 29 |
| spleen | 100% | 454.27 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 6.60 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 3.71 | 1 / 1 |
| adipose | 100% | 457.99 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 302.16 | 1333 / 1335 | 0% | 0 | 0 / 0 |
| heart | 96% | 230.36 | 823 / 861 | 0% | 0 | 0 / 0 |
| muscle | 94% | 140.31 | 758 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 69% | 4.27 | 55 / 80 |
| peripheral blood | 50% | 306.46 | 461 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0016925 | Biological process | protein sumoylation |
| GO_0061665 | Molecular function | SUMO ligase activity |
| Gene name | KIAA1586 |
| Protein name | KIAA1586 protein E3 SUMO-protein ligase KIAA1586 (EC 2.3.2.-) (E3 SUMO-protein transferase KIAA1586) KIAA1586 |
| Synonyms | |
| Description | FUNCTION: E3 SUMO-protein ligase; facilitates UBE2I/UBC9-mediated SUMO2 modification of target proteins . |
| Accessions | ENST00000370733.5 [Q9HCI6-1] ENST00000545356.5 Q9HCI6 Q8N303 F5H2N6 |